Schedule 13G ownership disclosure

TRAVERE THERAPEUTICS INC

Common Stock · CUSIP: 89422G107

Event date: 2025-09-30

Filing-level shares
10,599,660
Percent of class
11.9%
  • JANUS HENDERSON GROUP PLC

    Shares: 10,599,660 · Class: 11.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000318
Form type
SCHEDULE 13G/A
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub